Summary Camellia oil (CO) microcapsules were developed using chitosan–soybean protein isolate (CS‐SPI) complexes as wall materials and transglutaminase (TGase) as the cross‐linking agent. Results indicated that CO/SPI under the ratio of 1:2 exhibited the highest microencapsulation efficiency and yield, possessing the best encapsulation effect. Morphology observation showed that CO microcapsules were intact, compact and nearly spherical. The microencapsulated CO exhibited the improved thermal resistance and significantly lower peroxide values after 3 days storage, demonstrating that the produced microcapsule was a promising way to maintain the thermal and oxidative stability of camellia oil. It could be found evidence from FTIR, which indicated that covalent cross‐linking and hydrogen bonding might be involved among wall materials, and physical interactions between the core and wall materials. Therefore, the produced CO microcapsules could be an effective way to protect camellia oil, which was helpful for improving the processing and storage qualities of camellia oil.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: